Biotricity, Inc. BTCY
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.62% | 6.59% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.62% | 6.59% | |||
| Cost of Revenue | -12.39% | 15.66% | |||
| Gross Profit | 3.88% | 4.54% | |||
| SG&A Expenses | 44.91% | -14.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.83% | 0.26% | |||
| Operating Income | -77.24% | 57.54% | |||
| Income Before Tax | -195.96% | 54.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -195.96% | 54.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -195.96% | 54.79% | |||
| EBIT | -77.24% | 57.54% | |||
| EBITDA | -77.07% | 57.32% | |||
| EPS Basic | -191.19% | 61.78% | |||
| Normalized Basic EPS | -266.20% | 56.97% | |||
| EPS Diluted | -191.19% | 61.78% | |||
| Normalized Diluted EPS | -266.20% | 56.97% | |||
| Average Basic Shares Outstanding | -19.15% | 3.54% | |||
| Average Diluted Shares Outstanding | -19.15% | 3.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.66% | -1.21% | |||